#####
Currently, there are 525.10M common shares owned by the public and among those 515.14M shares have been available to trade.
#####
#####
#####
The company’s stock has a 5-day price change of 3.63% and 12.93% over the past three months. PCAR shares are trading -7.79% year to date (YTD), with the 12-month market performance down to -5.23% lower. It has a 12-month low price of $84.65 and touched a high of $115.49 over the same period. PCAR has an average intraday trading volume of 2.81 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.46%, 4.06%, and -2.59% respectively.
Institutional ownership of Paccar Inc (NASDAQ: PCAR) shares accounts for 71.64% of the company’s 525.10M shares outstanding.
It has a market capitalization of $51.75B and a beta (3y monthly) value of 0.91. The stock’s trailing 12-month PE ratio is 16.91, while the earnings-per-share (ttm) stands at $5.83. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.30% over the week and 2.41% over the month.
Analysts forecast that Paccar Inc (PCAR) will achieve an EPS of 1.3 for the current quarter, 1.43 for the next quarter and 6.59 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.16 while analysts give the company a high EPS estimate of 1.16. Comparatively, EPS for the current quarter was 1.85 a year ago. Earnings per share for the fiscal year are expected to decrease by -29.44%, and 16.63% over the next financial year. EPS should shrink at an annualized rate of -3.73% over the next five years, compared to 11.52% over the past 5-year period.
#####
Looking at the support for the PCAR, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on April 30, 2025, with the firm’s price target at $90. Morgan Stanley coverage for the Paccar Inc (PCAR) stock in a research note released on April 16, 2025 offered a Equal-Weight rating with a price target of $96. UBS on their part issued Neutral rating on March 18, 2025.
